Gladstone Institutional Advisory LLC

Position in AVXL — Anavex Life Sciences Corp.

CIK 1766530 Bedminster, NJ

Position in AVXL

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$222,209

-$21,665 QoQ

Shares Held

72,381

+5.7% QoQ

Ownership

0.078%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

9 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

Gladstone Institutional Advisory LLC holds $2,203,514 across 10 Biotechnology names. AVXL ranks #6 (10.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	6,091	$573,284
2	IBRX	ImmunityBio, Inc.	51,418	$394,376
3	VKTX	Viking Therapeutics, Inc.	9,552	$310,822
4	SRPT	Sarepta Therapeutics, Inc.	13,885	$302,137
5	REGN	Regeneron Pharmaceuticals, Inc.	383	$295,921
6	AVXL	Anavex Life Sciences Corp. This page	72,381	$222,209
7	GALT	Galectin Therapeutics Inc	23,900	$66,681
8	CRDF	Cardiff Oncology, Inc.	13,000	$21,060

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$222,209	72,381	+5.7%	Shares	Sole	2026-05-14
2025-12-31	$243,874	68,504	+15.1%	Shares	Sole	2026-02-17
2025-09-30	$529,808	59,529	+19.6%	Shares	Sole	2025-10-22
2025-06-30	$458,833	49,765	+56.4%	Shares	Sole	2025-08-12
2025-03-31	$272,972	31,815	+22.3%	Shares	Sole	2025-05-15
2024-12-31	$279,401	26,015	+44.5%	Shares	Sole	2025-01-29
2023-06-30	$146,340	18,000	-0.9%	Shares	Sole	2023-08-10
2023-03-31	$155,631	18,160	0.0%	Shares	Sole	2023-05-12
2022-12-31	$168,161	18,160	—	Shares	Sole	2023-02-01
No filing history on record for this holder in this stock.